Navigating Trial Complexity with RBQM: Practical Strategies for Adopting Risk-Based Approaches
Webinars
By submitting, you agree to the processing of your personal data by eClinical Solutions as described in our Privacy Policy.
Getting Life Sciences Back to Better
The COVID-19 pandemic has and will have far reaching impact across the life sciences industry that present numerous opportunities and challenges. How organizations adapt to the changing environment impacts both the shape of the current industry and the future of medicine and drug development. This panel discussion will share a variety of perspectives and strategies on how the biopharmaceutical industry can emerge from this period stronger than ever and how drug development is transforming based on trends, technology, processes and resources.
Topics Covered
- What trends have developed during the pandemic that have long-lasting impact on the industry? And are there any “fads” that are not as likely to have lasting impact?
- With the focus on therapies for COVID-19, how can other types of therapies come back into focus for companies developing new methods of treating disease?
- How does the industry need to change to adapt to this new environment across people, process, technology and mindsets?
- How does organization size impact strategy and how can emerging organizations thrive in this environment?
- What opportunities have been created by the pandemic and how can companies take advantage of them?
Who Should Attend
Leaders from across the biopharmaceutical industry in clinical operations, business operations, medical and safety, data management and biostatistics.
Presenters
CEO, eClinical Solutions
A technologist with over 25 years of industry experience, Raj Indupuri is responsible for establishing the eClinical Solutions vision and future-looking technology strategy. He is deeply passionate about fostering innovation to revolutionize the Life Sciences industry with ground-breaking technologies that will modernize clinical trials and bring treatments to patients faster. As an industry veteran who has been part of the evolution of Life Sciences and clinical data management for over two decades, Raj has an astute business vision to realize the digital future and enable progress and potential with data and analytics at the core of the company’s innovative products and solutions. Raj is responsible for the overall direction and management of the company and is a Mechanical Engineer with an MBA from Boston University who firmly believes data is the new fuel that will drive human progress.
President & CEO, Biocom Board of Directors
Biocom is the California association that advocates for 1300 companies, service sector firms, universities and research institutes working in the biotechnology and biomedical device arena.
Joe guides Biocom by setting strategic direction, guiding policy priorities, and championing the biopharmaceutical industry at the local, state, national, and international level.
President & CEO, Thread Research
Thread enables virtual visits +eCOA to conduct decentralized trials.
John’s career includes 17+ years leading global drug development and healthcare innovation. He was named one of the Top 100 Influencers in Digital Health.
